Autolus Therapeutics Ltd reported -47920000 in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
AstraZeneca USD 2.45B 466M Jun/2025
Autolus Therapeutics Ltd -47920000 22.24M Jun/2025
Hikma Pharmaceutical USD 133M 93M Dec/2024
Novartis USD 4.02B 418M Jun/2025
Roche Holding CHF 1.01B 2.12B Dec/2024
Silence Therapeutics -27012000 11.45M Sep/2024